Influence of pravastatin on blood lipids and serum high sensitive C-reactive protein in patients undergoing conventional coronary artery bypass grafting under on-pump: A clinical study of 81 cases

National Medical Journal of China

Volumn 88, Issue 2, 2008, Pages 101-104

  Wang, Xi Sheng ^a   Mei, Yun Qing ^b   Lu, Ya Feng ^b   Cai, Jian Zhi ^b   Ji, Qiang ^b   Tang, Chu Zhong ^b   Li, Tian Chang ^b   Hu, Da Yi ^b  

^a TONGJI HOSPITAL OF TONGJI UNIVERSITY   (China)

^b NONE

Author keywords

Blood lipids; C reactive protein; Coronary artery bypass; Pravastatin

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; TRIACYLGLYCEROL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY SURGERY; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; HUMAN; MAJOR CLINICAL STUDY; ON PUMP CORONARY SURGERY; PATIENT MONITORING; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PROTEIN BLOOD LEVEL; SURGICAL TECHNIQUE; TRIACYLGLYCEROL BLOOD LEVEL;

ANTICHOLESTEREMIC AGENTS; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERY BYPASS; HUMANS; LIPIDS; PRAVASTATIN; TRIGLYCERIDES;

EID: 41549137533     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Chinese source.
2. Sgoutas DS, Lattouf OM, Finlayson DC, et al. Paradoxical response of plasma Lipoprotein (a) in patients undergoing cardiopulmonary bypass Atherosclerosis,1992,97:29-36.
3. Guvener M, Ucar I, Ozkan M, et al. Effect of cardiopulmonary bypass on plasma levels of Lipoprotein(a) in hypercholesterolemic patients. Jpn heart J, 2001,42:563-574.
4. Lazar HL. Role of statin therapy in the coronary bypass patient. Ann Thorac Surg, 2004,78:730-740.
5. Khanderia U, Townsend KA, Eagle K, et al. Statin initiation following coronary artery bypass grafting: outcome of a hospital discharge protocol. Chest,2005,127:455-463.
6. Flaker GC, Warnica JW, Sacks FM, et al. Pravastatin prevents clinical events in revascularized patients with average cholesterol concentration. Cholesterol and Recurrent Events CARE Investigators. J Am Coll Cardiol,1999,34:106-112.
7. Schulze C, Conrad N, Schutz A, et al. Reduced expression of systemic proinflammatory cytokines after off -pump versus conventional coronary artery bypass grafting. Thor Cardiovasc Surg, 2000,48:364-369.
8. Maseri A. Inflammation, atherosclerosis and ischemic events exploring the hidden side of moon. N Engl J Med, 1997, 336: 1014-1016.
9. Guvener M, Ucar I, Ozkan M, et al. Effect of cardiopulmonary bypass on plasma levels of lipoprotein(a) in hypercholesterolemic patients. Jpn Heart J,2001,42:563-574.
10. Werba JP, Tremoli E, Massironi P, et al. Statins in coronary bypass surgery: rationale and clinical use. Ann Thorac Surg, 2003,76:2132-2140.